Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2008 1
2011 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
Brion A, Mahé B, Kolb B, Audhuy B, Colombat P, Maisonneuve H, Foussard C, Bureau A, Ferrand C, Lesesve JF, Béné MC, Feugier P; Groupe Ouest Est d’Etude des Leucémies et autres Maladies du Sang. Brion A, et al. Bone Marrow Transplant. 2012 Apr;47(4):542-8. doi: 10.1038/bmt.2011.117. Epub 2011 Jul 4. Bone Marrow Transplant. 2012. PMID: 21725374 Clinical Trial.
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N, Berthou C, Desablens B, de Guibert S, Delwail V, Moles MP, Quittet P, Jais JP, Colonna P, Andrieu JM; Groupe Ouest-Est d'Etude des Leucémies et Autres Maladies du Sang. Arakelyan N, et al. Cancer. 2008 Dec 15;113(12):3323-30. doi: 10.1002/cncr.23979. Cancer. 2008. PMID: 18988286 Free article. Clinical Trial.
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy.
Limat S, Woronoff-Lemsi MC, Milpied N, Chartrin I, Ifrah N, Deconinck E, Gressin R, Colombat P, Cahn JY, Arveux P; Groupe Ouest Est d'étude des Leucémies et Autres Maladies du Sang (GOELAMS). Limat S, et al. Eur J Cancer. 2000 Dec;36(18):2360-7. doi: 10.1016/s0959-8049(00)00327-0. Eur J Cancer. 2000. PMID: 11094310 Clinical Trial.